We've established the Evan T. Mandeville DIPG Research Fund at Dana-Farber Cancer Institute in memory of our son Evan who, on November 13, 2012, lost his battle to Diffuse Intrinsic Pontine Glioma (DIPG). He was just 11 years old.
Evan participated in two clinical trials during his exactly one year battle. Clinical trials are the ONLY hope for this devastating diagnosis. We are doing what we can to support efforts to find a cure for DIPG; this rare, always fatal and under-funded pediatric brain tumor.
100% of all donations made through the Pan-Mass Challenge go directly to Evan's research fund.
Dr. Mark Kiernan, MD, Ph.D
Pediatric Neuro-Oncologist speaking to the importance of funding.
We are helping
Evan T. Mandeville Research Fund: DIPG Report
Reprinted with permission from Dana-Farber Cancer Institute. To learn more, visit www.dana-farber.org."
Progress
Research Fund
DIPG Research at Dana-Farber:
Evan's Crew: Towards a cure for DIPG